PLEASANTON, Calif., May 23, 2025
/PRNewswire/ -- Movano Health (Nasdaq: MOVE)(the
"Company") announced today that it received a notice (the "Notice")
from the Listing Qualifications Department of the Nasdaq Stock
Market ("Nasdaq") indicating that because the Company had not yet
filed its Form 10-Q for the quarterly period ended March 31, 2025 (the "Form 10-Q"), the Company was
not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing
Rule") requiring Nasdaq-listed companies to timely file all
periodic financial reports with the Securities and Exchange
Commission (the "SEC"). The Form 10-Q was due on May 15, 2025.
The Notice states that the Company has 60 calendar days, or
until July 21, 2025, to submit a plan
to regain compliance with the Listing Rule (the "Plan"). If Nasdaq
accepts the Company's Plan to regain compliance, then Nasdaq may
grant the Company up to 180 calendar days from the Form 10-Q filing
due date, or until November 11, 2025,
to file its Form 10-Q to regain compliance. If Nasdaq does not
accept the Company's Plan, then the Company will have the
opportunity to appeal that decision to a Nasdaq Hearings Panel.
About Movano Health
Founded in 2018, Movano Inc. (Nasdaq: MOVE) dba Movano Health is
developing a suite of purpose-driven healthcare solutions to bring
medical-grade data to the forefront of wearables. Featuring modern
and flexible form factors, Movano Health's devices offer an
innovative approach to delivering trusted data to both customers
and enterprises, capturing a comprehensive picture of an
individual's health data and uniquely translating it into
personalized and intelligent insights.
Movano Health's proprietary technologies and wearable medical
device solutions enable the use of data as a tool to proactively
monitor and manage health outcomes across a number of patient
populations that exist in healthcare. For more information on
Movano Health, visit https://movanohealth.com/.
Forward Looking Statements
This press release contains forward-looking statements
concerning our expectations, anticipations, intentions, beliefs, or
strategies regarding the future. These forward-looking statements
are based on assumptions that we have made as of the date hereof
and are subject to known and unknown risks and uncertainties that
could cause actual results, conditions, and events to differ
materially from those anticipated. Therefore, you should not place
undue reliance on forward-looking statements. Examples of
forward-looking statements include, among others, statements
relating to the Company's plan to regain compliance with Nasdaq's
rules and the timing thereof. Actual results could differ
materially from those expressed in or implied by the
forward-looking statements due to a number of risks and
uncertainties, including but not limited to the timing of the
Company's submission of a compliance plan, Nasdaq's acceptance of
any such plan, and the duration of any extension that may be
granted by Nasdaq; the potential inability to meet Nasdaq's
requirements; uncertainties associated with the Company's
preparation of the Delinquent Filing; and the possibility of
additional delays in the filing of the delinquent filing and the
Company's other SEC filings. Important factors that could cause
actual results to differ materially from those in the
forward-looking statements are set forth in our most recent Annual
Report on Form 10-K and any subsequent Quarterly Reports on Form
10-Q, and in our other reports filed with the Securities and
Exchange Commission, including under the caption "Risk Factors."
Any forward-looking statement in this release speaks only as of the
date of this release. We undertake no obligation to publicly update
any forward-looking statement, whether written or oral, that may be
made from time to time, whether as a result of new information,
future developments or otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/movano-health-receives-notification-of-deficiency-from-nasdaq-related-to-delayed-filing-of-quarterly-report-on-form-10-q-302464510.html
SOURCE Movano